scholarly journals The Impact of mHealth Interventions on Breast Cancer Awareness and Screening: Systematic Review Protocol

2017 ◽  
Vol 6 (12) ◽  
pp. e246 ◽  
Author(s):  
Temitope O Tokosi ◽  
Jill Fortuin ◽  
Tania S Douglas
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Systematic Review Protocol ◽  
Cancer Awareness ◽  
Breast Cancer Awareness ◽  
Review Protocol ◽  
The Impact

scholarly journals The Impact of mHealth Interventions on Breast Cancer Awareness and Screening: Systematic Review Protocol (Preprint)

2017 ◽  
Author(s):  
Temitope O Tokosi ◽  
Jill Fortuin ◽  
Tania S Douglas
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Health Care ◽  
Search Strategy ◽  
Cochrane Central Register ◽  
Cancer Awareness ◽  
Breast Cancer Awareness ◽  
Statistical Heterogeneity ◽  
Message Service ◽  
The Impact

BACKGROUND Mobile health (mHealth) is the use of mobile communication technologies to promote health by supporting health care practices (eg, health data collection, delivery of health care information). mHealth technologies (such as mobile phones) can be used effectively by health care practitioners in the distribution of health information and have the potential to improve access to and quality of health care, as well as reduce the cost of health services. Current literature shows limited scientific evidence related to the benefits of mHealth interventions for breast cancer, which is the leading cause of cancer deaths in women worldwide and contributes a large proportion of all cancer deaths, especially in developing countries. Women, especially in low- and middle-income countries (LMICs), are faced with low odds of surviving breast cancer. This finding is likely due to multiple factors related to health systems: low priority of women’s health and cancer on national health agendas; lack of awareness that breast cancer can be effectively treated if detected early; and societal, cultural, and religious factors that are prevalent in LMICs. The proposed systematic review will examine the impact of mHealth interventions on breast cancer awareness and screening among women aged 18 years and older. OBJECTIVE The objectives of this study are to identify and describe the various mHealth intervention strategies that are used for breast cancer, and assess the impact of mHealth strategies on breast cancer awareness and screening. METHODS Literature from various databases such as MEDLINE, EMBASE, PsycINFO, CINAHL, and Cochrane Central Register of Controlled Trials will be examined. Trial registers, reports, and unpublished theses will also be included. All mobile technologies such as cell phones, personal digital assistants, and tablets that have short message service, multimedia message service, video, and audio capabilities will be included. mHealth is the primary intervention. The search strategy will include keywords such as “mHealth,” “breast cancer,” “awareness,” and “screening,” among other medical subject heading terms. Articles published from January 1, 1964 to December 31, 2016 will be eligible for inclusion. Two authors will independently screen and select studies, extract data, and assess the risk of bias, with discrepancies resolved by dialogue involving a third author. We will assess statistical heterogeneity by examining the types of participants, interventions, study designs, and outcomes in each study, and pool studies judged to be statistically homogeneous. In the assessment of heterogeneity, a sensitivity analysis will be considered to explore statistical heterogeneity. Statistical heterogeneity will be investigated using the Chi-square test of homogeneity on Cochrane's Q statistic and quantified using the I-squared statistic. RESULTS The search strategy will be refined with the assistance of an information specialist from November 1, 2017 to January 31, 2018. Literature searches will take place from February 2018 to April 2018. Data extraction and capturing in Review Manager (RevMan, Version 5.3) will take place from May 1, 2018 to July 31, 2018. The final stages will include analyses and writing, which is anticipated occur between August 2018 and October 2018. CONCLUSIONS The knowledge derived from this study will inform health care stakeholders, including researchers, policy makers, investors, health professionals, technologists, and engineers, on the impact of mHealth interventions on breast cancer screening and awareness. CLINICALTRIAL Prospero registration number CRD42016050202

The impact of breast cancer awareness and socioeconomic status on willingness to receive breast cancer prevention drugs

2006 ◽  
Vol 101 (1) ◽  
pp. 95-104 ◽  
Author(s):  
Peter A. Fasching ◽  
Gunter von Minckwitz ◽  
Thorsten Fischer ◽  
Manfred Kaufmann ◽  
Beate Schultz-Zehden ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Socioeconomic Status ◽  
Cancer Prevention ◽  
Breast Cancer Prevention ◽  
Cancer Awareness ◽  
Breast Cancer Awareness ◽  
The Impact ◽  
To Receive

scholarly journals Systematic review protocol exploring the impact of the COVID-19 pandemic on the wellbeing of general practitioners

2021 ◽  
Author(s):  
Laura Jefferson ◽  
Su Golder ◽  
Veronica Dale ◽  
Holly Essex ◽  
Elizabeth McHugh ◽  
...  
Keyword(s):  
Mental Health ◽  
Systematic Review ◽  
Quality Assessment ◽  
General Practitioners ◽  
Systematic Reviews ◽  
Assessment Tools ◽  
Systematic Review Protocol ◽  
Health And Wellbeing ◽  
Review Protocol ◽  
The Impact

Background Over recent years chronic stress and burnout have been reported by doctors working in general practice in the UK NHS and internationally. The COVID-19 pandemic has changed general practitioners working lives; adding potential pressures from avoiding infection and addressing pent-up demand for care, but also changing processes such as rapidly taking up remote consultations. To date, there has been a focus on exploring the impact of the pandemic on the wellbeing of hospital clinicians. No registered systematic reviews currently focus on exploring the impact of the pandemic on the mental health and wellbeing of general practitioners. Aims and objectives To synthesise the current international evidence base exploring the impact of COVID-19 on the mental health and wellbeing of general practitioners, and which factors are associated with their reported mental health and wellbeing during the pandemic. Methods In this paper we report a systematic review protocol, following PRISMA guidance. In our search strategy we will identify primary research studies or systematic reviews exploring the mental health and wellbeing of general practitioners during the COVID-19 pandemic in four databases (MEDLINE, Embase, PsychInfo and Medrxiv) and Google Scholar. We will hand-search reference lists and grey literature. Two reviewers will undertake all stages including study selection, data extraction and quality assessment, with arbitration by a third reviewer where necessary. We will use standardised quality assessment tools to ensure transparency and reduce bias in quality assessment. Depending on the quality of included studies, we may undertake a sensitivity analysis by excluding studies from narrative synthesis that are rated as low quality using the checklists. We will describe the findings across studies using narrative thematic data synthesis, and if sufficiently homogenous data are identified, we will pool quantitative findings through meta-analysis.

scholarly journals Screening strategies for hypertension: a systematic review protocol

BMJ Open ◽  
2019 ◽  
Vol 9 (1) ◽  
pp. e025043 ◽  
Author(s):  
Bey-Marrié Schmidt ◽  
Solange Durão ◽  
Ingrid Toews ◽  
Charlotte M Bavuma ◽  
Joerg J Meerpohl ◽  
...  
Keyword(s):  
Systematic Review ◽  
Latin American ◽  
Data Extraction ◽  
Controlled Trials ◽  
Publication Date ◽  
Cochrane Central Register ◽  
Systematic Review Protocol ◽  
Screening Strategies ◽  
Review Protocol ◽  
The Impact

IntroductionIt is unclear whether early detection of hypertension, through screening, leads to healthier behaviours and better control of blood pressure levels. There is a need to learn from studies that have assessed the impact of different screening approaches on patient important outcomes. This systematic review protocol outlines the methods that will be used to assess the comparative effectiveness of different screening strategies (mass, targeted or opportunistic) for hypertension to reduce morbidity and mortality associated with hypertension.Methods and analysisWe will primarily search Cochrane Central Register of Controlled Trials, Medline, Embase and Latin American and Caribbean Health Sciences Literature (LILACS). Relevant randomised controlled trials, controlled before and after, interrupted time series and prospective analytic cohort studies regardless of publication date, language and geographic location, will be included. We are interested in clinical, adverse event and health system outcomes. Two reviewers will independently screen titles, abstracts and full-text articles against inclusion criteria; perform data extraction and assess risk of bias in included studies. We will assess the certainty of the overall evidence using the Grading of Recommendations Assessment, Development and Evaluation approach and report findings accordingly.Ethics and disseminationNo ethics approval will be sought, as only secondary studies will be used. Findings will be disseminated through peer-reviewed publication and conference presentations.PROSPERO registration numberCRD42018093046.

scholarly journals The impact of financial incentives on physical activity in adults: a systematic review protocol

2018 ◽  
Vol 7 (1) ◽  
Author(s):  
My-Linh Nguyen Luong ◽  
Kim L. Bennell ◽  
Michelle Hall ◽  
Anthony Harris ◽  
Rana S. Hinman
Keyword(s):  
Physical Activity ◽  
Systematic Review ◽  
Financial Incentives ◽  
Systematic Review Protocol ◽  
Review Protocol ◽  
The Impact

The impact of selective DNA methyltrasferase inhibitors on breast cancer: A systematic review protocol (Preprint)

2018 ◽  
Author(s):  
◽  
Mahsa Mohammadamoli 2nd ◽  
Negar Sarhangi 3rd ◽  
Seyed Mohammad Tavangar 4th
Keyword(s):  
Breast Cancer ◽  
Systematic Review ◽  
Dna Methyltransferase ◽  
Best Practice ◽  
Breast Cancer Patients ◽  
Data Synthesis ◽  
Dna Methyltransferase Inhibitors ◽  
Oncological Diseases ◽  
Review Protocol ◽  
The Impact

UNSTRUCTURED The DNA methyltransferase inhibitors (DNMTi) are the greatest effective epigenetic drugs to date and are still the most widely used as epigenetic modulators, even though their application for oncological diseases is restricted by their relative toxicity and poor chemical stability. Unfortunately, there is no a review related to the studies related to different DNMTi and breast cancer treatment. This review the DNMTi impact on breast cancer therapy, through the available literature we will run a systematic review. The specific review questions to be addressed are: (1) what constitutes current best practice in relation DNMTi interventions for hospitalized breast cancer patients? (2) What are the indications for, and the safety and effectiveness of, the range of interventions available? This protocol represented the methods including: inclusion criteria search strategy, Selection of studies, Quality assessment, and the last but not the least Statistical analysis and data synthesis which will be passed throughout of our research.

Sign in / Sign up

Export Citation Format

Share Document